Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Maxwell Targets $500B Cosmetics Market with Microbiome-Friendly Antiseptics
Via Newsfile
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property Product Safety
Kaplan Fox is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
Via NewMediaWire
Exposures Product Safety
Tickers UNCY
Kaplan Fox is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
Via TheNewswire.com
Exposures Product Safety
Tickers UNCY
BioMedNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands U.S. Forensic Market Presence Through SMARTOX Partnership
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis Product Safety
Tickers INBS
Ralf van Veen Unveils Secrets to Startup Success in Exclusive Interview
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Lantern Pharma Inc. (NASDAQ: LTRN) Is ‘One to Watch’
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers LTRN
Novavax’s Covid-Flu Combo, Standalone Flu Vaccines Demonstrate Robust Immune Response In Late-Stage Trial: Retail Says It’s ‘A Very Good Sign’
Via Stocktwits
Exposures COVID-19 Product Safety
Tickers IWM NVAX VTI
Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs
Via FinancialNewsMedia
Exposures Product Safety
Tickers ONCY TSX:ONC
EXCLUSIVE: Intelligent Bio Solutions Expands US Forensic Market Presence, Seeks FDA Clearance For Fingerprint Drug Testing
Via Benzinga
Exposures Product Safety
Tickers INBS
CRL Q1 Earnings Call: Regulatory Changes and Market Stabilization Shape Outlook
Via StockStory
Topics Animal Testing
Exposures Animal Testing Product Safety
Tickers CRL
Kaplan Fox Announces an Investigation Into Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
Via TheNewswire.com
Exposures Product Safety
Tickers UNCY
Kaplan Fox Announces an Investigation Into Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
Via NewMediaWire
Exposures Product Safety
Tickers UNCY
Why Gilead Scinces Stock Tumbled on Tuesday
Via The Motley Fool
Exposures Product Safety
Tickers GILD
Delta-8 Hemp Carts: Top-Rated Disposable Vape Cartridges Launched By HALF BAK’D
Via Press Release Distribution Service
Exposures Product Safety
Bitcoin Mining Stock With 'Biggest Opportunity' In Crypto Space Grabs Eyeballs As Expert Recalls Tom Lee's Call: 'If We Are In For Another Leg Up In BTC, This Flies'
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers BITB BTCO FBTC GBTC
Gelteq Stock Soars On Deal With Healthy Extracts For Product Distribution In North America: Retail Chatter Explodes
Via Stocktwits
Exposures Product Safety
Tickers GELS GILD
Coverfour Alarms Leads the Way in Home Fire Protection with Advanced Commercial-Grade Systems
Via AB Newswire
Topics Lawsuit Product Recall
Exposures Financial Legal Product Safety
US FDA Places Clinical Hold On Gilead Trials Of Two Investigational HIV Treatments: Retail’s On The Fence
Via Stocktwits
Exposures Product Safety
Tickers GILD RY TSX:RY VOO
Omeros Analyst Sees $1 Billion Potential For Narsoplimab Before FDA Decision
Via Benzinga
Exposures Product Safety
Tickers OMER
TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at 2025 BIO International Convention
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Medicus Pharma Ltd. (NASDAQ: MDCX) Positioned for Growth in a $5 Trillion Biotech Market
Via AB Newswire
Exposures Product Safety
Tickers MDCX
Easy Qualification For Low-Cost Semaglutide Weight Loss Injections: 2025 Update
Via Press Release Distribution Service
Exposures Product Safety
1 Cash-Producing Stock on Our Buy List and 2 to Be Wary Of
Via StockStory
Exposures Product Safety
Tickers DXCM KNX MU
BioMedNewsBreaks — Panna Sharma, Lantern Pharma CEO, Says FDA’s Elsa AI Rollout Underscores Urgency to Modernize
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers BMWYY LTRN
ABCS Releases Statement on Letybo, New FDA-Approved Botox Alternative
Via Press Advantage
Exposures Product Safety
FDA Pushes Pause On Axsome Fibromyalgia Drug, New Trial Required
Via Benzinga
Exposures Product Safety
Tickers AXSM
Axsome Stock Slips Pre-Market After FDA Issues Refusal-To-File Letter: Retail’s Skeptical On Likelihood Of Year-End Profitability
Via Stocktwits
Topics Stocks
Exposures Product Safety US Equities
Tickers AAPL AXSM TSLA
Corrado Garibaldi: The Self-Taught Trader Who Profits by Defying the Crowd
Via Press Release Distribution Service
Topics Artificial Intelligence Bonds Product Recall
Exposures Artificial Intelligence Debt Markets Legal
Michael Bloom Advocates for Emotional and Cultural Competence in Nursing
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Phathom Pharmaceuticals Stock Doubles After FDA Grants Full 10-Year Exclusivity For Voquezna
Via Benzinga
Exposures Product Safety
Tickers PHAT
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.